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Abstract
Background: The Body Mass Index (BMI) and Waist Circumference (WC) are well-used anthropometric predictors for
cardiovascular diseases (CVD), but their validity is regularly questioned. Recently, A Body Shape Index (ABSI) and Body
Roundness Index (BRI) were introduced as alternative anthropometric indices that may better reflect health status.
Objective: This study assessed the capacity of ABSI and BRI in identifying cardiovascular diseases and cardiovascular disease
risk factors and determined whether they are superior to BMI and WC.
Design and Methods: 4627 Participants (54612 years) of the Nijmegen Exercise Study completed an online questionnaire
concerning CVD health status (defined as history of CVD or CVD risk factors) and anthropometric characteristics. Quintiles of
ABSI, BRI, BMI, and WC were used regarding CVD prevalence. Odds ratios (OR), adjusted for age, sex, and smoking, were
calculated per anthropometric index.
Results: 1332 participants (27.7%) reported presence of CVD or CVD risk factors. The prevalence of CVD increased across
quintiles for BMI, ABSI, BRI, and WC. Comparing the lowest with the highest quintile, adjusted OR (95% CI) for CVD were
significantly different for BRI 3.2 (1.4–7.2), BMI 2.4 (1.9–3.1), and WC 3.0 (1.6–5.6). The adjusted OR (95% CI) for CVD risk
factors was for BRI 2.5 (2.0–3.3), BMI 3.3 (1.6–6.8), and WC 2.0 (1.6–2.5). No association was observed for ABSI in both groups.
Conclusions: BRI, BMI, and WC are able to determine CVD presence, while ABSI is not capable. Nevertheless, the capacity of
BRI as a novel body index to identify CVD was not superior compared to established anthropometric indices like BMI and
WC.
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Introduction
Overweight and obesity are the fifth leading cause of global
death and are an increasing worldwide health problem. In 2008,
more than 1.4 billion adults suffered from overweight and within
this group approximately 36% adults is obese [1]. Overweight and
obesity are associated with an increased risk for cardiovascular
diseases (CVD), type 2 diabetes mellitus and premature death [2–
9]. Therefore, an early detection of overweight or obesity is
considered necessary to prevent CVD [10].
The Body Mass Index (BMI) and Waist Circumference (WC)
are currently recommended by several guidelines to classify
overweight and obesity [10,11]. Indeed, an increase in BMI or
WC has been shown to be a risk factor for CVD [10]. However,
previous studies also demonstrated that the discriminative capacity
of BMI is not optimal, as this calculation cannot distinguish
between adipose tissue and lean body mass [12–16]. WC
alternatively, has been shown to be a good predictor for
abdominal adipose tissue [17,18], but currently it is unclear to
what extent the range of WC depends on body size [19,20]. This
has led to the idea that by combining traditional measures (e.g.
height, weight, BMI, or WC) a better body index could be
designed, which takes body shape into account [21–24].
Recently, two new body indices have been introduced [22,23].
In 2012, Krakauer et al. developed ‘A Body Shape Index’ (ABSI),
which is based on waist circumference (m), BMI (kg?m22), and
height (m) [22]. According to the authors, a high ABSI relates to a
greater fraction of abdominal adipose tissue and appears to be a
significant risk factor for premature death [22]. Other studies have
suggested that ABSI is able to predict the onset of diabetes mellitus
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[25] and that it could be used to evaluate physical health status of
adolescents [26]. In 2013, Thomas et al. developed the Body
Roundness Index (BRI), which is a new geometrical index that
combines height (m) and waist circumference (m) to predict the
percentage of body fat and to evaluate health status [23].
However, it is unknown whether ABSI and BRI can determine
the presence or risk of cardiovascular diseases.
Therefore, the aim of this study was to assess the capacity of the
novel indices A Body Shape Index (ABSI) and Body Roundness
Index (BRI) to identify cardiovascular diseases and cardiovascular
disease risk factors in the Dutch population and to determine
whether these anthropometric indices are superior to the Body
Mass Index and Waist Circumference. We postulate that ABSI
and BRI can better identify CVD than BMI or WC.
Methods
Ethics Statement
The study adhered to the Declaration of Helsinki. The Local
Committee on Research Involving Human Subjects (CMO) of the
region Arnhem and Nijmegen approved the study, and all subjects
gave their written informed consent.
Study design and study population
The Nijmegen Exercise Study (www.nijmegenexercisestudy.
com) is a large-population based study conducted by the
Department for Health Evidence and the Department of
Physiology of the Radboud University Medical Center in June
2011. The overall aim of the Nijmegen Exercise Study is to
examine the effects of physical activity on general health and
various disease outcomes in the general population.
In 2011, participants of the International Nijmegen Four Days
Marches, the largest multi-day walking event in the world, were
eligible to participate in the Nijmegen Exercise Study. By means of
a passive recruitment strategy (Four Days Marches newsletter and
internet advertisement), Dutch speaking adults were invited to
complete an online survey. Participants were asked about their
date of birth, anthropometric measures (weight, height, and WC),
and whether they were diagnosed with CVD. In addition,
participants were questioned about their lifestyle factors (physical
activity and smoking habits).
Anthropometric measures
Self-reported body height, weight, and waist circum-
ference. Participants reported their height (centimetre), waist
circumference (centimetre), and body weight (kilogram) in the
online survey. Each anthropometric measurement was accompa-
nied with detailed instructions. These data were used to calculate
the BMI, ABSI, and BRI according to standardized formulas.
BMI was based on weight (kg) and height (m) and calculated using
formula [1] [27].
BMI~
weight
height2
ð1Þ
A body shape index. The ABSI was based on height (m),
BMI (kg?m22), and waist circumference (m) and calculated using
formula [2] [22].
ABSI~
WC
BMI2=3|height1=2
ð2Þ
The Body Roundness Index. The BRI was based on height
(m) and waist circumference (m). First, the eccentricity (e) of the
body was determined using formula [3]. Eccentricity (non-
dimensional value) quantifies the degree of circularity of an
ellipse, and it ranges between zero (perfect circle) to one (a vertical
line) [23].
"~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1{
WC= 2pð Þð Þ2
0:5|heightð Þ2
 !vuut ð3Þ
Subsequently, the BRI was calculated using formula [4].
Described by Thomas et al., values closer to 1 are related to
leaner individuals, whereas larger values are associated with
rounder individuals [23].
BRI~364:2{(365:5|") ð4Þ
Presence of cardiovascular diseases
Participants were asked whether their physician diagnosed (yes/
no) presence of CVD (1. myocardial infarction and 2. stroke) or
CVD risk factors (1. hypertension and 2. hypercholesterolemia).
Participants were categorized in the CVD or CVD risk factor
group if one of these questions were replied positively, while they
were allocated to the control group if all answers were negative.
Participants who reported CVD as well as CVD risk factors were
allocated to the CVD group.
Lifestyle factors
All participants reported whether they had followed a training
program prior to the Nijmegen Four Days Marches and/or
whether they performed other sport activities (e.g. playing soccer,
tennis, etc.). Based on the duration (hours/week), frequency, and
intensity (low, moderate, high) of these exercise activities, the
average time and intensity level of physical activity per day was
Figure 1. Flowchart enrolment of the study population. 5742
participants completed the online questionnaire. 1115 participants
were excluded because of missing data (n = 1065), pregnancy (n = 7), or
BMI ,18.5 (n = 43). The final group sample consisted of 4627
participants.
doi:10.1371/journal.pone.0107212.g001
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calculated. The recommendations of the American Heart Asso-
ciation were used to determine if a participant fulfilled the physical
activity criteria [28].
Participants reported whether they were current smoker, ex-
smoker or non-smokers and were categorized as (ex)-smoker or
non-smoker.
Calculations and statistical analysis
Group characteristics were analysed using descriptive tech-
niques. Continuous variables (age, height, weight, ABSI, BMI,
BRI, and WC) were reported in tables as mean and differences
between the CVD, CVD risk factor, and control group were
analysed using one-way analysis of variance (ANOVA) with a
Bonferroni post-hoc test. Categorical data were reported in
proportions and differences tested by Pearson’s chi-squared test
(sex, physical activity, myocardial infarction, stroke, hypertension,
hypercholesterolemia, and smoking). Statistical significance was
assumed at P,0.05.
Pairwise correlation coefficients between the continuous vari-
ables height, weight, ABSI, BMI, BRI, and WC were assessed by
calculating Pearson correlation coefficients. To examine the
discriminative power of the anthropometric indices for CVD or
CVD risk factors the Area under the Receiver Operating
Characteristic (AROC) curves were calculated. The AROC
represents a measure of accuracy of an anthropometric index to
discriminate between subjects with or without CVD or CVD risk
factors [29].
Quintiles of BMI and BRI were created and the prevalence of
CVD and CVD risk factors was calculated in each quintile. Since
ABSI is strongly correlated with age and sex [22], ABSI was
stratified for age (per year), after which ABSI quintiles were
determined within each age group for males and females
separately. To calculate the prevalence of CVD and CVD risk
factors per ABSI quintile, subjects within the same ABSI quintile
were merged. For WC the quintiles were stratified by sex and the
prevalence of CVD and CVD risk factors in each quintile was
calculated. Logistic regression was used to estimate the odds ratio
for suffering from CVD or CVD risk factors per quintile, both
unadjusted and adjusted for sex, age, and lifestyle factors (smoking
and physical activity). For all four anthropometric indices, the
lowest quintile was set as reference. All statistical analyses were
performed using SPSS 20.0 (IBM Corp. Released 2011. IBM
SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM
Corp) software.
Results
5742 participants completed the online questionnaire. After the
exclusion of participants who were pregnant, had underweight
(calculated BMI of ,18.5), or with missing data on anthropomet-
ric measures, the study population consisted of 4627 (80.6%)
participants (Figure 1). This included 2425 men (57.5611.4 years
of age) and 2202 women (50.2612.6 years of age). 1332 (27.7%)
participants reported CVD or CVD risk factors, of which 32.9%
(438) were female. Hypertension and hypercholesterolemia were
reported in respectively 19.5% and 14.6% of the study population.
Myocardial infarction and stroke were reported in respectively
2.6% and 1.4% of the study population (Table 1).
Table 1. Characteristics of the total study population and according to cardiovascular disease status.
Parameters Group
n 4627
Sex, % females (n) 47.6 (2202)
CVD and risk factors, %yes (n) 23.2 (1332)
MI, %yes (n) 2.6 (121)
Stroke, %yes (n) 1.4 (65)
Hypertension, %yes (n) 19.5 (903)
Hypercholesterolemia, %yes (n) 14.6 (674)
CVD CVD risk factors Controls P-value
n 179 1153 3295 –
Sex, % females (n) 9.5 (17)*,** 36.5 (421)* 53.5 (1764) ,0.001
Age (years) 62.9 (68.3)*,** 59.6 (68.8)* 51.6 (613.0) ,0.001
Height (cm) 176.4 (67.3)*,** 174.4 (68.8) 174.5 (69.1) 0.020
ABSI (m11/6?kg22/3) 0.084 (60.005)*,** 0.082 (60.005)* 0.081 (60.006) ,0.001
BMI (kg?m22) 26.2 (63.0)*,** 25.6 (63.1)* 24.4 (63.0) ,0.001
BRI 4.5 (61.1)*,** 4.2 (61.1)* 3.7 (61.2) ,0.001
Weight (kg) 81.6 (611.5)*,** 78.1 (613.1)* 74.5 (612.6) ,0.001
WC (cm) 97.9 (69.0)*,** 94.4 (610.3)* 89.8 (611.0) ,0.001
Norm PA (%yes [n]) 66.5 (119) 67.4 (777)* 59.2 (1949) ,0.001
Smoking (%yes [n]) 71.5 (128)*,** 61.6 (710)* 49.5 (1631) ,0.001
Abbreviations: ABSI, A Body Shape Index; BRI, Body Roundness Index; BMI, Body Mass Index; MI, Myocardial Infarction; norm PA, norm physical activity;
Data presented as mean (SD) or proportion (number).
*significantly different from ‘Controls’;
** significantly different from ‘ CVD risk factors’.
doi:10.1371/journal.pone.0107212.t001
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CVD, CVD risk factor and control group characteristics
The participants with CVD and CVD risk factors were older
(62.968.3 vs. 59.668.8 vs. 51.6613.0 year; P,0.001) compared
the control group. The CVD and CVD risk factor group reported
a higher body weight (81.6 (611.5) vs. 78.1 (613.1) vs.
74.5612.6 kg; P,0.001) and smoked more often (71.5% vs.
61.6% vs. 49.5%; P,0.001). There were more participants
physically active within the CVD risk factor group compared the
control group (67.4 vs. 59.2; P,0.001), whereas the CVD and
control group were comparable (66.5 vs. 59.2; P=0.06) (Table 1).
Furthermore, participants with CVD and CVD risk factors
demonstrated higher ABSI, BMI, BRI, and WC values compared
to the control group (Table 1).
Correlation and AROC scores
ABSI and BRI were positively and significantly correlated to
height, weight, BMI and WC (Table 2; Figure 2). Within the
CVD group, the AROC scores were 0.63 for ABSI, 0.68 for BRI,
0.64 for BMI, and 0.69 for WC (Figure 3A). Within the CVD risk
factor group, the AROC scores were 0.57 for ABSI, 0.63 for BRI,
0.60 for BMI, and 0.61 for WC (Figure 3B).
Prevalence of CVD and CVD risk factors
The prevalence of CVD increased per quintile for all four
anthropometric indices (1st quintile vs. 5th quintile): ABSI 3.9% vs.
4.3%, BRI 0.8% vs. 6.5%, BMI 1.0% vs. 6.1%, WC 1.0% vs.
6.1% (P,0.05) (Table 3A). The prevalence of CVD risk factors
increased per quintile for all four anthropometric indices (1st
quintile vs. 5th quintile): ABSI 23.2% vs. 24.1%, BRI 11.6% vs.
36.9%, BMI 15.0% vs. 34.2%, WC 15.0% vs. 34.2% (P,0.05)
(Table 3B).
Odds of cardiovascular diseases
The unadjusted odds of CVD prevalence increased with
increasing quintiles for ABSI (ORunadjusted =1.1 [0.721.8]), BRI
(ORunadjusted =9.1 [4.1220.1]), BMI (ORunadjusted =6.7 [3.32
13.5]), and WC (ORunadjusted =3.4 [1.926.3]) (Table 4). Physical
activity was non-significant in the logistic regression analysis and
was therefore excluded from further analysis. After adjustment for
age, sex, and smoking, the odds ratio of CVD was still significant
for BRI (ORadjusted 3.2 [1.427.2]), BMI (ORadjusted=3.3 [1.62
6.8]), and WC (ORadjusted =3.0 [1.625.6]). However, the odds
ratios did not vary across the ABSI quintiles (ORadjusted=1.1 [0.72
1.8]) (Table 4).
Odds of cardiovascular disease risk factors
The unadjusted odds of CVD risk factor prevalence increased
with increasing quintiles for ABSI (ORunadjusted=1.1 [0.821.3]),
BRI (ORunadjusted =4.5 [3.525.7]), BMI (ORunadjusted =2.9 [2.32
3.7]), and WC (ORunadjusted=2.4 [2.023.0]) (Table 5). After
adjustment for age, sex, and smoking, the odds ratio of CVD
was still significant for BRI (ORadjusted 2.5 [2.023.3]), BMI
(ORadjusted =2.4 [1.923.1]), and WC (ORadjusted =2.0 [1.622.5).
However, the odds ratios did not vary across the ABSI quintiles
(ORadjusted =1.1 [0.921.3]) (Table 5).
Discussion
We demonstrated that the prevalence of CVD and CVD risk
factors significantly increased across the quintiles for ABSI, BRI,
BMI, and WC. However, after adjusting for age, sex, and smoking
only BRI, BMI, and WC could identify CVD or CVD risk factors
and not ABSI. In contrast to our hypothesis, neither ABSI nor
BRI are superior measures compared to BMI and WC to
determine the presence of CVD or CVD risk factors. Our findings
indicate that the novel index ABSI is not suitable for identifying
CVD or CVD risk factors, while the BRI showed similar
capabilities as BMI and WC.
A Body Shape Index
The ABSI was created to produce a quantitative measure to
estimate the health of body shape independently of body size
(height, weight, and BMI) [22]. While Krakauer et al. demon-
strated that ABSI predicts premature mortality better than BMI or
WC [22], our results suggest that ABSI cannot be used to
distinguish between individuals with and without CVD or CVD
risk factors. Compared with BRI, BMI, and WC, the ABSI
demonstrated the lowest predictive power and had no significant
association with CVD or CVD risk factors prevalence after
adjustment for age, sex, and smoking. Thus, ABSI is not a suitable
measurement to identify CVD and CVD risk factors.
A possible explanation for the contrasting findings between our
data and Krakauer et al., is the endpoint variable, namely the
prevalence of CVD and CVD risk factors versus premature death.
Alternatively, subject characteristics may explain the dissimilarities
between our study and the one of Krakauer et al. [30]. Our study
population has approximately the same ABSI values as Krakauer
i.e. 0.08160.0058 m11/6?kg22/3 vs. 0.08160.0053 m11/6?kg22/3,
but surprisingly our study population had a lower BMI (3rd
quintile: 23.7–25.2 vs. 25.6–28.4) and lower WC (3rd quintile
females: 82–87 vs. 88–97; males: 94–98 vs. 94–101). The
explanation why ABSI is similar is that our study population
Table 2. Correlations between body size and shape.
Height Weight WC ABSI BRI BMI
Height 1
Weight 0.69** 1
WC 0.40** 0.79** 1
ABSI 0.18** 0.18** 0.68** 1
BRI 20.04* 0.54** 0.90** 0.64** 1
BMI 0.11** 0.79** 0.75** 0.09** 0.77** 1
ABSI: A Body Shape Index; BRI: Body Roundness Index; BMI: Body Mass Index; WC; Waist Circumference.
Correlation coefficients between height, weight, ABSI, BMI, BRI, and WC among the NES study population (n = 4627). **Correlation is significant at the 0.01 level (2-
tailed). *Correlation is significant at the 0.05 level (2-tailed).
doi:10.1371/journal.pone.0107212.t002
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comprising Dutch subjects were taller compared to the American
study population of Krakauer et al. The estimated average body
height is 1.70 meters in the study of Krakauer et al., whereas our
study population had an average body height of 1.75 meters. This
suggests that body height might confound the capacity of ABSI to
identify CVD in our study population. Future studies should
further investigate the limits of ABSI and especially study the
impact of body height on the calculation of ABSI.
Body Roundness Index
We are the first to study the capacity of BRI to identify CVD
and CVD risk factors. The BRI was developed to predict both
Figure 2. Correlations between ABSI, BMI, BRI, and WC. A. Correlation between ABSI and BMI. Increase in ABSI and increase in BMI show a
poor yet significant correlation (r= 0.087, P,0.001). B. Correlation between ABSI and WC. Increase in ABSI and increase in WC show a significant
correlation (r= 0.678, P,0.001). C. Correlation between BRI and BMI. Increase in BRI and increase in BMI show a significant correlation (r=0.780, P,
0.001). D. Correlation between BRI and WC. Increase in BRI and increase in WC show a significant correlation (r = 0.898, P,0.001). E. Correlation
between BRI and ABSI. Increase in BRI and increase in ABSI show a significant correlation (r = 0.642, P,0.001).
doi:10.1371/journal.pone.0107212.g002
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body fat and the percentage visceral adipose tissue by using WC
in relation to height, which allows estimation of the shape of the
human body figure as an ellipse or oval [23]. We demonstrated
that the BRI is capable to identify CVD and CVD risk factors
(Table 3). This is in agreement with previous studies [21,24]
which also related WC to body height (i.e. waist-to-height ratio
[WtH-ratio]). The spearman rank test revealed a perfect
nonlinear relation between BRI and WtH-ratio (r=1;
P=0.00). This indicates that both body indices are related by
an one-to-one nonlinear transformation and strictly means that
it does not matter what index (BRI or WtH-ratio) is used to
determine CVD. However, as demonstrated by Thomas et al.,
the advantage of the BRI over the WtH-ratio is that it also can
be used to estimate the amount of body fat percentage and
gives therefore a better impression of physical health status.
Although the adjusted OR of the BRI was higher compared to
BMI and WC, this did not reach statistical significance.
Nevertheless, we recommend that future studies should study
the sensitivity of BRI to determine cardiovascular health risks in
a clinical setting. With the development of computerized
software that is accessible via internet websites, Tablets or
Smartphone applications, novel body measures with complex
algorithms can easily be used by physicians [22,23]. Therefore,
the BRI has the potential to improve the detection, evaluation,
and progression of CVD and CVD risk factors.
Methodological considerations
Our study compared the ABSI and BRI mutually and against
the BMI and WC in a large heterogeneous study population. In
our study, participants self-reported their weight and WC using
our written instructions, whilst in the study of Krakauer et al.
trained personnel measured WC. Although, it is likely that
participants made some measurement errors, prior studies
demonstrated that self-report of body weight and waist circum-
ference is a validated and feasible method [31,32]. We therefore
suppose that self-reporting has had a minor influence on our
Table 3. Prevalence of CVD and CVD risk factors in quintiles of ABSI, BRI, BMI, and WC.
Cardiovascular diseases
Quintile ABSI BRI BMI WC
1 (%CVD [n]) 3.9 (34) 0.8 (7) 1.0 (9) 1.0 (9)
2 (%CVD [n]) 3.4 (31) 1.9 (18) 2.4 (22) 2.4 (22)
3 (%CVD [n]) 3.8 (35) 3.8 (35) 4.4 (41) 4.4 (41)
4 (%CVD [n]) 4.0 (37) 6.4 (59) 5.4 (50) 5.4 (50)
5 (%CVD [n]) 4.3 (42) 6.5 (60) 6.1 (57) 6.1 (57)
Cardiovascular disease risk factors
Quintile ABSI BRI BMI WC
1 (%CVD [n]) 23.2 (204) 11.6 (107) 15.0 (139) 15.0 (139)
2 (%CVD [n]) 25.9 (239) 20.1 (186) 21.4 (198) 21.4 (198)
3 (%CVD [n]) 25.8 (239) 29.7 (275) 25.6 (237) 25.6 (237)
4 (%CVD [n]) 25.5 (235) 26.4 (244) 28.4 (262) 28.4 (262)
5 (%CVD [n]) 24.1 (236) 36.9 (341) 34.2 (317) 34.2 (317)
ABSI: A Body Shape Index; BRI: Body Roundness Index; BMI: Body Mass Index; WC; Waist Circumference.
Data presented as mean (SD) or proportion (number).
doi:10.1371/journal.pone.0107212.t003
Figure 3. The discriminatory power of ABSI, BRI, BMI, and WC between subjects with or without CVD or CVD risk factors. A. Area
under the Receiver Operating Characteristic curve of ABSI, BRI, BMI, and WC to identify subjects with cardiovascular diseases. B. Area under the
Receiver Operating Characteristic curve of ABSI, BRI, BMI, and WC to identify subjects with cardiovascular disease risk factors.
doi:10.1371/journal.pone.0107212.g003
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findings. Additionally, the outcome variable (CVD) was self-
reported; participants were only allowed to report CVD or CVD
risk factors if they were diagnosed by a physician. Possibly some
participants had a history of CVD and did not report this. This
could have led to an underestimation of our results. Therefore, the
capacity of BRI, BMI, and WC to identify CVD or CVD risk
factors could somewhat be higher. Finally, one might argue that
the cross-sectional nature of our study is suboptimal to study the
predictive capacity of anthropometric characteristics. However, in
our study design we demonstrated that the BRI as well as BMI and
WC were able to identify participants with CVD. It is a first step in
validating BRI in relation to CVD and therefore we believe that
the used method is appropriate. In future studies, the longitudinal
relation between BRI and CVD incidence should be studied.
Table 5. The odds of CVD and CVD risk factor prevalence for quintiles of ABSI, BRI, BMI, and WC adjusted for sex, age, and
smoking.
Cardiovascular diseases
Quintile ABSI BRI BMI WC
1 (reference) 1 1 1 1
2 0.8 (0.521.4) 1.3 (0.523.2) 1.5 (0.723.4) 2.5 (1.324.8)W
3 1.0 (0.621.6) 2.1 (0.924.8) 2.5 (1.225.2)* 2.3 (1.224.4)W
4 1.0 (0.621.7) 3.1 (1.426.9)W 2.8 (1.325.8)W 3.0 (1.625.7)W
5 1.1 (0.721.8) 3.2 (1.427.2)W 3.3 (1.626.8)W 3.0 (1.625.6)W
Cardiovascular disease risk factors
Quintile ABSI BRI BMI WC
1 (reference) 1 1 1 1
2 1.2 (0.921.5) 1.3 (1.021.7) 1.3 (1.021.7)* 1.3 (1.021.6)*
3 1.2 (0.921.5) 2.0 (1.622.6)W 1.6 (1.222.0)W 1.4 (1.121.7)W
4 1.2 (0.921.4) 1.6 (1.222.1)W 1.7 (1.422.2)W 1.5 (1.221.9)W
5 1.1 (0.921.3) 2.5 (2.023.3)W 2.4 (1.923.1)W 2.0 (1.622.5)W
ABSI: A Body Shape Index; BRI: Body Roundness Index; BMI: Body Mass Index; WC; Waist Circumference.
Ranges in parentheses are 95% confidence intervals. The between cut points are 0.077, 0.080, 0.083, and 0.086 for ABSI; 2.8, 3.5, 3.9, 4.7 for BRI; 22.1, 23.7, 25.2, and 27.1
for BMI; 0.89, 0.94, 0.98, 1.04 for WC (males); 0.78, 0.82, 0.87, 0.94 for WC (females).
*Significant at P,0.05; WSignificant at P,0.01.
doi:10.1371/journal.pone.0107212.t005
Table 4. The unadjusted odds of CVD and CVD risk factor prevalence for ABSI, BRI, BMI, and WC.
Cardiovascular diseases
Quintile ABSI BRI BMI WC
1 (reference) 1 1 1 1
2 0.9 (0.521.4) 2.6 (1.126.3)* 2.5 (1.125.4)* 2.6 (1.424.9)W
3 1.0 (0.621.6) 5.2 (2.3211.7)W 4.7 (2.329.8)W 2.7 (1.525.0)W
4 1.0 (0.621.7) 8.9 (4.1219.7)W 5.8 (2.9212.0)W 3.4 (1.926.3)W
5 1.1 (0.721.8) 9.1 (4.1220.1)W 6.7 (3.3213.5)W 3.4 (1.926.3)W
Cardiovascular disease risk factors
Quintile ABSI BRI BMI WC
1 (reference) 1 1 1 1
2 1.2 (0.921.4) 1.9 (1.522.5)W 1.5 (1.222.0)W 1.4 (1.121.8)W
3 1.1 (0.921.4) 3.2 (2.524.1)W 1.9 (1.522.5)W 1.7 (1.322.1)W
4 1.1 (0.921.4) 2.7 (2.123.5)W 2.2 (1.822.8)W 1.8 (1.522.3)W
5 1.1 (0.821.3) 4.5 (3.525.7)W 2.9 (2.323.7)W 2.4 (2.023.0)W
ABSI: A Body Shape Index; BRI: Body Roundness Index; BMI: Body Mass Index; WC; Waist Circumference.
Ranges in parentheses are 95% confidence intervals. The between cut points are 0.077, 0.080, 0.083, and 0.086 for ABSI; 2.8, 3.5, 3.9, 4.7 for BRI; 22.1, 23.7, 25.2, and 27.1
for BMI; 0.89, 0.94, 0.98, 1.04 for WC (males); 0.78, 0.82, 0.87, 0.94 for WC (females).
*Significant at P,0.05; WSignificant at P,0.01.
doi:10.1371/journal.pone.0107212.t004
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Conclusion
In the current study, we demonstrated that CVD and CVD risk
factors prevalence increased per quintile across a heterogeneous
population for ABSI, BRI, BMI, and WC. Nonetheless, only BRI,
BMI, WC, and not ABSI, could significantly determine the
presence of CVD and CVD risk factor after correction for sex, age
and smoking. The capacity of BRI to mathematically model the
human body shape gives an adequate impression of the
cardiovascular health status, but was not superior to BMI or WC.
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